Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heat-stable carbetocin versus oxytocin for treatment of postpartum haemorrhage after vaginal birth
ISRCTN92079573Phase 3Recruiting
- Sponsor
- World Health Organization
- Start
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
01
Overview
Phase 3, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Heat-stable carbetocin with Oxytocin (2 arms). Primary endpoint: Additional vaginal blood loss at least 500 mL by 90 minutes. Started Mar 2024; status: recruiting.
02
Drugs
heat-stable carbetocinoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ISRCTN92079573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN92079573.